Newly Added Classes


Catheter Ablation of VT in Normal Hearts
Reviewing key points on catheter ablation of ventricular tachycardia (VT) in structurally normal hearts 
Website


Catheter Ablation of VT in Structural Heart Disease
Reviewing key points on catheter ablation of ventricular tachycardia (VT) in structural heart disease
Website


Contemporary Review of Mapping and Ablation of Cardiac Arrhythmias
The goal of this activity is to review arrhythmia mechanisms and cardiac anatomy for the EP professional. To review SVT arrhythmia differentiation in the EP lab. To review fundamentals of AF and VT ablation procedures. CME Released: 9/20/2017 Valid for credit through: 9/20/2018 
Website


High Density Multi-electrode Catheters Are Required to Successfully Map Complex Atrial Arrhythmias
The goal of this activity is to discuss the existing new tools regarding their ability to map with high density complex arrhythmia. To outline possible indications for the use of multielectrode catheters. CME Released: 9/20/2017 Valid for credit through: 9/20/2018 
Website


2017 Remote Monitoring Update Webinar
This 3-part series will highlight recommendations outlined in the 2015 HRS consensus statement:  Remote Monitoring Interrogation and Monitoring for Cardiovascular Implantable Electronic Devices and provide an update on clinical comparative effectiveness studies published since 2015 for remote monitoring. CME Released: 10/10/2017 Valid for credit through: 10/31/2018 
Website


2017 HRS/EHRA/ECAS/APHRS/SOLAECE Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation
May 12, 2017 The 2017 Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation represents a complete rewrite of the 2012 HRS/EHRA/ECAS Expert Consensus Statement. This document provides updated definitions, mechanisms, and rationale for atrial fibrillation (AF) ablation and consensus recommendations concerning indications, strategies, techniques, and endpoints, technology and tools, and follow-up considerations for AF ablation.
Website


Advances in Antithrombotic Treatment for the Prevention of Stroke in Patients with AF
The goal of this activity is to present clinical trial outcomes from the NOAC trials in Asian patients with AF, to review guideline recommendations, as well as discuss clinical practice patterns related to anticoagulant therapy revealed in Asian registry data. CME Released: 12/14/2016 Valid for credit through: 12/14/2017
Website


ADVICE: Adenosine-Guided PVI Ablation Reduces Atrial Tachyarrhythmia Recurrence
The use of adenosine to identify and eliminate dormant pulmonary vein conduction during radiofrequency ablation of paroxysmal atrial fibrillation (AF) significantly reduces recurrent atrial tachyarrhythmias, according to the results of a large, prospective, multicenter trial.
Website


AF and PCI: Tailoring Antithrombotic Therapy to Optimize Outcomes
The goal of this activity is to provide an update on the clinical challenges of treating patients with atrial fibrillation who now need a percutaneous coronary intervention with regard to combining oral anticoagulants and antiplatelet therapy. Valid for credit through: 6/20/2018
Website


AFib Treatment Adherence Drives Outcomes
The diagnosis and treatment of Atrial Fibrillation is increasing world-wide. The following compilation of presentations address the impact of treatment adherence (both physician and patient) on outcomes and suggests ways to help providers increase the level of patient adherence to the treatment plan. CE Credit through 9/2/2018.
Website


an Long Work Hours Increase Risk for New-Onset AF?
Upon completion of this activity, participants will be able to: Compare the risk for new-onset atrial fibrillation among persons working long hours (≥55 h per week) with that of persons working standard hours (35-40 hours/week), based on a large, prospective, multicohort study Describe clinical implications regarding the association between work hours and risk for new-onset atrial fibrillation, according to a large, prospective, multicohort study Valid for credit through: 8/11/2018
Website


Atrial Fibrillation: There's More to Worry About Than Stroke
The goal of this activity is to highlight the CV risks associated with the presence of comorbidities in patients with AF, and the role of anticoagulation in reducing risk and improving outcomes in these patients. Authors Jonathan L. Halperin, MD; Shinya Goto, MD, PhD; Fausto Pinto, MD, PhD; Christian T. Ruff, MD, MPH CME / ABIM MOC Released: 1/23/2017 Valid for credit through: 1/23/2018
Website


Cardiac Device Infections: Pathologies and Management Implications
Video - By Cleveland Clinic Heart Rhythm Society 2014 Symposium Featuring Sohail Rizwan
Website


Case Presentation: Walking Through a Case of Epicardial VT Ablation
Case Presentation: Walking Through a Case of Epicardial VT Ablation by Dr. Kalyanam Shivkumar, UCLA Health System, Los Angeles, CA. Presented at the Cleveland Clinic Heart Rhythm Society 2014 Symposium.
Website


Catheter Ablation for Ventricular Tachycardia
What is the long-term safety and effectiveness of radiofrequency catheter ablation (RFCA) in patients with coronary artery disease and sustained monomorphic ventricular tachycardia (SMVT)? - See more at: http://www.acc.org/Latest-in-Cardiology/Journal-Scans/2016/02/09/15/36/Long-Term-Success-of-Irrigated-Radiofrequency-Catheter-Ablation?
Website


Challenging Cases in Atrial Fibrillation Management: Issues of Anticoagulation
Challenging Cases in Atrial Fibrillation Management: Issues of Anticoagulation by Dr. Eric Prystowsky, FACC Director of Cardiovascular, St Vincent Hospital, Indianapolis, IN.
Website


CIED infection: Incidence, Predictors, Strategies for Prevention
Featuring Bruce Wilkoff
Website


Comparative Chronic Valve and Venous Effects of Lumenless versus Stylet-Delivered Pacing Leads in Patients with and Without Congenital Heart
A study of 134 pediatric patients with and without congenital heart defects showed that a lumenless 4.1 Fr diameter pacing lead (Medtronic Model 3830) was associated with less adverse impact on atrioventricular valve integrity and venous obstruction compared to 5-7 Fr diameter pacing leads.
Website


Confluent Extended Posterior Left Atrial Wall Ablation: Thinking Inside the Box
Here, we report intermediate follow-up details after using a technique of confluent posterior left atrial wall epicardial ablation designed to eliminate both existing and future atrial fibrillation (AF) substrates. The method is part of the Convergent hybrid procedure for AF ablation.
Website


Cutting the cord: Leadless electrophysiology devices in practice
By Dr. Gaurav Upadhyay, University of Chicago, Chicago, IL. Presented at Innovations in Cardiovascular Therapeutics 2016.
Website


Drivers in Relation to Duration of Persistent Atrial Fibrillation
What are the mechanisms and preferential sites of driver activity in patients with persistent atrial fibrillation (AF)?
Website


ECG of the Month
List of monthly ECG quizzes.
Website


Enhancing Outcomes with Technology Advancements in Treating AF
CME Released: 2/5/2017; Valid for credit through 2/5/2018. Review the current state of AF and growing trends that may impact future care. Examine the impact of 3D mapping tools, contact force ablation, and additional emerging techniques and technologies that may support improved outcomes. Evaluate techniques and technologies for optimizing AF monitoring. Assess different approaches for mapping persistent AF.
Website


Enhancing Outcomes with Technology Advancements in Treating AF CME
This activity features expert presentations and interactive discussions that assess current challenges and technological advancements to improve AF outcomes. The distinguished faculty examines the current state of AF and growing trends; including 3D mapping tools, contact force ablation, monitoring for AF, and optimal approaches for mapping persistent AF. CME Released: 2/5/2017; Valid for credit through 2/5/2018
Website


How Innovations and Cybersecurity Impact Physicians and the Patients We Treat
Evaluate the importance of maintaining and enhancing medical device integrity in the dynamic and ever evolving cybersecurity environment, while considering the potential patient health, safety and confidentiality impacts of cybersecurity in the context of medical technologies in healthcare. Review the balance for protecting patient safety and promoting the development of innovative technologies and improved technology performance. Review how to ensure the evaluation of cybersecurity is integrated with a holistic assessment of potential impacts on patient health, safety, and security of patient data, and health information, so patient and physician needs are balanced, and clinical perspectives considered with cybersecurity throughout the product lifecycle. Gain understanding of the cybersecurity policies and procedures and communication processes that govern implantable devices throughout the product lifecycle. Gain understanding of evolving communication standards and tools of the future that will enhance cybersecurity of implanted medical devices.
Website


Improve the prevention of sudden cardiac arrest in emerging countries: the Improve SCA clinical study design.
Primary prevention patients with syncope/pre-syncope, non-sustained VT, frequent PVCs, or LVEF < 25% risk factors (categorized as 1.5 Prevention) have been shown to be at similar risk of VT/VF as secondary prevention patients. The Improve SCA study will enroll 4800 ICD-eligible patients from Asia, Latin America, Eastern Europe, the Middle East, and Africa in order to confirm this risk, providing additional geographical-relevant evidence to inform shared decision making.
Website


Improving Persistent AF Ablation Outcomes through a Multidisciplinary Approach
Review large unmet clinical need and challenges of treating persistent AF with current ablation approaches. Evaluate the safety and efficacy of dual epicardial and endocardial ablation for treating persistent or longstanding persistent AF. Assess outcomes data and clinical experiences for comprehensive posterior left atrial ablation in persistent AF patients.CME Released: 6/7/2017; Valid for credit through 6/7/2018
Website


Individual patient data network meta-analysis of mortality effects of implantable cardiac devices.
An individual patient-level meta-analysis of 13 randomized trials (n = 12,638) was performed to estimate the comparative mortality effects of ICDs, CRT-Ps, and CRT-Ds. These data can be used to estimate an individual patient's expected and inform shared benefit decision making.
Website


Journal CME/HeartRhythm Journal: August 2016 Vol. 13, Issue 8: Spontaneous vs. Nitroglycerin-induced Vasovagal Reflex on Head-up Tilt: Are There Neuroendocrine Differences?
Head-up tilt test (HUT) has been used for nearly 30 years for diagnosing vasovagal syncope (VVS) and was enhanced by sublingual nitroglycerin (glyceryl trinitrate [GTN]) challenge in the 1990s. The purpose of this study was to explore neuroendocrine differences between spontaneous and drug-induced HUT positivity. Good for credit through 7/28/2018
Website


Journal CME/HeartRhythm Journal: March 2017 Vol. 14, Issue 3: Delayed efficacy of radiofrequency catheter ablation on ventricular arrhythmias originating from the left ventricular anterobasal wall
Ventricular arrhythmias (VAs) originating from the left ventricular anterobasal wall (LV-ABW) may represent a therapeutic challenge. The purpose of this study was to investigate the delayed efficacy of radiofrequency catheter (RFCA) ablation without an epicardial approach on VAs originating from the LV-ABW. RELEASE DATE: 2/15/2017 EXPIRATION DATE: 2/23/2019 CME: 1
Website


Journal CME/HeartRhythm Journal: October 2016 Vol. 13, Issue 10: 'Wide-narrow-wide' QRS complex tachycardia. What is the mechanism?
The tracing of Figure 1 (leads II, III, and V1 taken simultaneously) has been recorded from a 58-year-old man during the recovery phase of exercise stress testing. At tachycardia onset,the R-R interval is relatively long but shortens over the course of the first few beats.Surprisingly, the event begins with wide QRS complexes, but suddenly beats 8-14 become relatively narrow and quite variable in duration and morphology.CME through 9/25/18
Website


Journal CME/HeartRhythm Journal: September 2016 Vol. 13, Issue 9: Flecainide versus digoxin for fetal supra ventricular tachycardia: comparison of two drug treatment protocols
The optimal treatment for fetal supraventricular tachycardia (SVT) with 1:1 atrioventricular relationship is unclear. We compared the effectiveness of transplacental treatment protocols used in two centers. CME through 8/24/2018
Website


Late-Breaking Clinical Trial: "The POWDER-AF Trial"
Several Late-Breaking Clinical Trials were presented at Heart Rhythm 2017. Click on the link below to watch Mattias Duytschaever, MD, PhD review the "Pulmonary Vein Isolation With Versus Without Continued Antiarrhythmic Drug Treatment In Subjects With Recurrent Atrial Fibrillation: Results From The POWDER-AF Multicentre Randomized Trial"
Website


Magnet Function with Medtronic Cardiac Devices" on Medtronic Academy.
This course and reference tool is designed for physicians, nurses, radiologists, and all other medical personnel managing patients with Medtronic pacemakers and ICDs. It describes: how a magnet affects Medtronic pacemaker and ICD devices, clinical scenarios where a magnet can be used, how to prepare and monitor a patient once the clinician determines a magnet should be used. Must register first through Medtronic.
Website


More Double Trouble: AF and Hypertension CME
Characterize the risk presented by patients with atrial fibrillation (AF) and hypertension Review the clinical trial experience with non-vitamin K antagonist oral anticoagulants (NOACs) vs warfarin in patients with hypertension
Website


Natalia Trayanova, PhD "Reentrant Drivers Anchoring to Structural Heterogeneities: A Major Pathophysiological Mechanism of Human Persistent AF"
The mechanisms underlying persistent atrial fibrillation (AF) in patients with atrial fibrosis are poorly understood. Evidence from recent clinical and experimental studies suggests that persistent AF might be maintained by reentrant drivers (i.e., rotors), but the mechanisms linking reentrant driver formation and persistent AF perpetuation remain unknown.
Website


On the Quest for the Best Freeze: Predictors of Late Pulmonary Vein Reconnections After Second-Generation Cryoballoon Ablation
The second-generation cryoballoon is effective in achieving acute pulmonary vein isolation (PVI) and favorable clinical outcome. To date, no data are available on factors affecting late PV reconnection after second-generation cryoballoon ablation.
Website


Optimizing CRT through Device Programming
The plan reviews CRT device follow-up steps, discusses clinical evidence on the impact of RV pacing, and provides an overview of device algorithms that help ensure delivery of cardiac resynchronization therapy.
Website


Patient Selection in Catheter Ablation for Atrial Fibrillation
Dr. Larry Chinitz, NYU Langone Medical Center, New York, NY. AF Ablation Video.
Website


Periprocedural Management of Anticoagulation
Dr. John Doherty, Thomas Jefferson University Hospital, Philadelphia, PA.
Website


Real-World Safety of NOACs: What Do We Know Today?
The goal of this activity is to improve understanding of real-world evidence regarding NOAC safety and efficacy. Valid for credit through: 6/2/2018
Website


Revealing Characteristics of Patients at High Risk for Developing AF
The goal of this activity is to provide the latest clinical trial data on the use of an insertable cardiac monitoring device in patients at risk of developing atrial fibrillation. Valid for credit through: 6/16/2018
Website


Stroke Prevention in Atrial Fibrillation: Advancements in Oral Anticoagulation Therapy and LAA Closure
The Program Director, Dr. Vivek Reddy, and world-renowned faculty, explore advancements in Left Atrial Appendage Closure (LAAC) and oral anticoagulation therapy for managing AF related stroke. Session highlights include Case Broadcasts from Mount Sinai Hospital, Device Reviews and Technical Considerations, AF-Related Stroke and Anticoagulation, LAAC Clinical Outcomes, Essentials for Advancing the Clinical Science, and Practical Aspects of LAAC.
Website


Surgical LAA Closure: Why, When and How
Evaluate systemic thromboembolization and the role of the LAA in patients with atrial fibrillation. Evaluate the efficacy of surgical LAA exclusion. Review Thoracoscopic LAA Closure, with and without lesions. CME Released: 2/17/2017; Valid for credit through 2/17/2018
Website


The Essentials for Secondary Stroke Prevention
Authors Gregory W. Albers, MD; Hans-Christoph Diener, MD, PhD CME / ABIM MOC Released: 3/22/2017 The goal of this activity is to highlight the management of patients who experienced a stroke and treatment options to mitigate the risks of a secondary stroke. Valid for credit through: 3/22/2018
Website


The Role of the PA for Successfully Managing Atrial Fibrillation Patients. Valid for credit through 7/10/2018
The webcast reviews the basic mechanisms of AF, limitations of existing therapy, optimal diagnosis and technological advancements for AF management, and the value of interdisciplinary collaboration for the achievement of optimal outcomes in AF management. 4 Webcasts for the CME are: A Basic Science Review on the Mechanisms of AF Andy C. Kiser, MD Identifying AF and How to Determine Treatment Strategies Kimberly Guise, MSN, ANP Advancements in Hybrid Ablation and LAA Closure Techniques and Technologies J. Paul Mounsey, BM, Bch, PhD Panel Discussion: Improving Interdisciplinary Collaboration Andy Kiser, MD, Kimberly Guise, MSN, ANP and J. Paul Mounsey, BM, Bch, PhD
Website


Treating Atrial Fibrillation: Challenging Patient Cases
Upon completion of this activity, participants will have increased knowledge regarding the use of non-vitamin K antagonist oral anticoagulants in the special populations of patients with atrial fibrillation. Valid for credit through: 7/27/2018.
Website